Header Logo

Connection

GAIL ECKHARDT to Antineoplastic Agents, Immunological

Back to Details
This is a "connection" page, showing publications GAIL ECKHARDT has written about Antineoplastic Agents, Immunological.
GAIL ECKHARDT
Connection Strength
0.141
Antineoplastic Agents, Immunological
  1. A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors. Ann Oncol. 2018 07 01; 29(7):1561-1568.
    View in: PubMed
    Score: 0.141
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.